EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Antimicrobial resistance profile of methicillin-resistant Staphylococcus aureus isolates in children reported from the ISPED surveillance of bacterial resistance, 2016–2021

Xia Wu, Chuanqing Wang, Leiyan He, Hongmei Xu, Chunmei Jing, Yinghu Chen, Aiwei Lin, Jikui Deng, Qing Cao, Huiling Deng, Huijun Cai, Yiping Chen und 5 weitere

Frontiers in Cellular and Infection Microbiology · 2023

DOI: 10.3389/fcimb.2023.1102779 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2023. Verfasst von Xia Wu und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Children's Hospital of Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Methicillin-Resistant Staphylococcus aureus, Staphylococcal Infections, Communicable Diseases. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Methicillin-resistant Staphylococcus aureus (MRSA) poses a serious threat to public health worldwide. In December 2015, the Infectious Disease Surveillance of Pediatrics (ISPED) program was organized to monitor bacterial epidemiology and resistance trends in children.

Methods

This retrospective study was conducted from January 2016–December 2021 on patients at eleven ISPED-group hospitals.

Results

From 2016–2021, a total of 13024 MRSA isolates were obtained from children. The most common age group for patients with MRSA infection was less than 3 years old, and newborns were an important group affected by MRSA infection. MRSA was most commonly isolated from the lower respiratory, an abscess, a secretion, or blood in neonates and from the lower respiratory, an abscess, or the upper respiratory in non-neonates. All isolates were susceptible to vancomycin and linezolid and resistant to penicillin; additionally, 76.88%, 54.97%, 22.30%, 5.67%, 5.14%, 3.63%, and 1.42% were resistant to erythromycin, clindamycin, tetracycline, levofloxacin, sulfamethoxazole-trimethoprim (TMP-SMX), gentamicin, and rifampin, respectively. Between 2016 and 2021, a significant increase was seen in the levofloxacin- and TMP-SMX-resistance rates (from 5.45% to 7.14% and from 4.67% to 6.50%, respectively) among MRSA isolates, along with a significant decrease in the rates of resistance to erythromycin (from 82.61% to 68.08%), clindamycin (from 60.95% to 46.82%), tetracycline (from 25.37% to 17.13%), gentamicin (from 4.53% to 2.82%), and rifampin (from 1.89% to 0.41%).

Discussion

The antibiotic-resistance rates varied among MRSA isolated from different sources. Because of the high antibiotic resistance rate to clindamycin, this antibiotic is not recommended for empirical treatment of MRSA infections, especially in osteomyelitis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Methicillin-Resistant Staphylococcus aureusStaphylococcal InfectionsCommunicable DiseasesInfant, NewbornChildHumansChild, PreschoolAnti-Bacterial AgentsClindamycinTrimethoprim, Sulfamethoxazole Drug CombinationLevofloxacinRetrospective StudiesStaphylococcus aureusRifampinAbscessDrug Resistance, BacterialErythromycinTetracyclineGentamicinsMicrobial Sensitivity Tests

Stichwörter der Autor:innen

antimicrobial resistancechildreninfectious disease surveillance of pediatrics (ISPED)methicillin-resistant Staphylococcus aureusneonates

Substanzen

Anti-Bacterial AgentsClindamycinTrimethoprim, Sulfamethoxazole Drug CombinationLevofloxacinRifampinErythromycinTetracyclineGentamicins

Autor:innen und Institutionen

  • Department of Infectious Diseases, Children's Hospital of Fudan University, Shanghai, China.
  • Department of Clinical Laboratory, Children's Hospital of Fudan University, Shanghai, China.
  • Department of Infectious Diseases, Children's Hospital of Chongqing Medical University, Chongqing, China.
  • Department of Clinical Laboratory, Children's Hospital of Chongqing Medical University, Chongqing, China.
  • Department of Infectious Diseases, Children's Hospital of Zhejiang University School of Medicine, Hangzhou, China.
  • Department of Infectious Diseases, Qilu Children's Hospital of Shandong University, Jinan, China.

Zitieren

APA

Wu, X., Wang, C., He, L., Xu, H., Jing, C., Chen, Y., Lin, A., Deng, J., Cao, Q., Deng, H., Cai, H., Chen, Y., Yang, J., Zhang, T., Huang, Y., Hao, J., & Yu, H. (2023). Antimicrobial resistance profile of methicillin-resistant Staphylococcus aureus isolates in children reported from the ISPED surveillance of bacterial resistance, 2016–2021. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2023.1102779

Vancouver

Wu X, Wang C, He L, Xu H, Jing C, Chen Y, et al. Antimicrobial resistance profile of methicillin-resistant Staphylococcus aureus isolates in children reported from the ISPED surveillance of bacterial resistance, 2016–2021. Frontiers in Cellular and Infection Microbiology. 2023. doi:10.3389/fcimb.2023.1102779

BibTeX
@article{Wu2023,
  author = {Wu, Xia and Wang, Chuanqing and He, Leiyan and Xu, Hongmei and Jing, Chunmei and Chen, Yinghu and Lin, Aiwei and Deng, Jikui and Cao, Qing and Deng, Huiling and Cai, Huijun and Chen, Yiping and Yang, Jinhong and Zhang, Ting and Huang, Yuanyuan and Hao, Jianhua and Yu, Hui},
  title = {Antimicrobial resistance profile of methicillin-resistant Staphylococcus aureus isolates in children reported from the ISPED surveillance of bacterial resistance, 2016–2021},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2023},
  doi = {10.3389/fcimb.2023.1102779}
}
Kostenlos starten →